Longitudinal adrenal gland measurements and growth trajectories as risk markers for late preterm delivery.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
29 Sep 2020
Historique:
received: 09 12 2019
accepted: 15 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 28 5 2021
Statut: epublish

Résumé

The fetal adrenal gland receives rising awareness as a predictor of spontaneous preterm birth. We hereby provide longitudinal growth assessments of the fetal adrenal gland in a low risk population with an additional focus on trajectories in fetuses born preterm. Fetal adrenal gland was assessed via transabdominal ultrasound at gestational weeks (gw) 24-26, 28-30, and 34-36 in a low-risk pregnancy cohort. Longitudinal trajectories of the total gland and the mark (so called fetal zone) as well as ratio of fetal zone width/ total widths (w/W) were analyzed using repeated ANOVA analyses. To compare trajectories of the ratio w/W for preterm and term fetuses respectively, as well as women with and without clinical signs of preterm labor, the propensity score method was applied. Fetal zone width increased over the course of pregnancy (p < 0.0001), while the ratio w/W decreased (p < 0.0001) (n = 327). Comparing the trajectories of the ratio w/W in fetuses born preterm (n = 11) with propensity-score matched term born fetuses (n = 22), a decrease between gw 24-26 and 28-30 was observed in both groups, which continued to decrease for the term born fetuses. However, in preterm born fetuses, the ratio increased above the term born values at gw 34-36. Our study provides for the first time longitudinal growth data on the fetal adrenal gland and supports the hypothesis that fetal zone enlargement is associated with preterm birth which could play an important role in risk-prediction.

Sections du résumé

BACKGROUND BACKGROUND
The fetal adrenal gland receives rising awareness as a predictor of spontaneous preterm birth. We hereby provide longitudinal growth assessments of the fetal adrenal gland in a low risk population with an additional focus on trajectories in fetuses born preterm.
METHODS METHODS
Fetal adrenal gland was assessed via transabdominal ultrasound at gestational weeks (gw) 24-26, 28-30, and 34-36 in a low-risk pregnancy cohort. Longitudinal trajectories of the total gland and the mark (so called fetal zone) as well as ratio of fetal zone width/ total widths (w/W) were analyzed using repeated ANOVA analyses. To compare trajectories of the ratio w/W for preterm and term fetuses respectively, as well as women with and without clinical signs of preterm labor, the propensity score method was applied.
RESULTS RESULTS
Fetal zone width increased over the course of pregnancy (p < 0.0001), while the ratio w/W decreased (p < 0.0001) (n = 327). Comparing the trajectories of the ratio w/W in fetuses born preterm (n = 11) with propensity-score matched term born fetuses (n = 22), a decrease between gw 24-26 and 28-30 was observed in both groups, which continued to decrease for the term born fetuses. However, in preterm born fetuses, the ratio increased above the term born values at gw 34-36.
CONCLUSION CONCLUSIONS
Our study provides for the first time longitudinal growth data on the fetal adrenal gland and supports the hypothesis that fetal zone enlargement is associated with preterm birth which could play an important role in risk-prediction.

Identifiants

pubmed: 32993527
doi: 10.1186/s12884-020-03255-6
pii: 10.1186/s12884-020-03255-6
pmc: PMC7526396
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

570

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : DI 2130/3-2
Organisme : Deutsche Forschungsgemeinschaft
ID : DI 2103/3-2
Organisme : Deutsche Forschungsgemeinschaft
ID : HE 4617/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : HE 4617/1-2
Organisme : Deutsche Forschungsgemeinschaft
ID : AR232/25-1
Organisme : Deutsche Forschungsgemeinschaft
ID : AR232/25-2

Références

Obstet Gynecol. 2008 Mar;111(3):715-22
pubmed: 18310376
Mol Cell Endocrinol. 2001 Dec 20;185(1-2):135-44
pubmed: 11738803
J Matern Fetal Neonatal Med. 2017 Mar;30(5):568-573
pubmed: 27075298
Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-8
pubmed: 19788970
Am J Obstet Gynecol. 2011 Apr;204(4):311.e1-10
pubmed: 21292230
Obstet Gynecol. 2007 Apr;109(4):855-62
pubmed: 17400846
J Clin Epidemiol. 2005 Jun;58(6):550-9
pubmed: 15878468
N Engl J Med. 1996 Feb 29;334(9):567-72
pubmed: 8569824
Am J Perinatol. 2012 Oct;29(9):673-80
pubmed: 22644825
Am J Epidemiol. 2003 Aug 1;158(3):280-7
pubmed: 12882951
N Engl J Med. 2007 Aug 2;357(5):462-9
pubmed: 17671254
J Matern Fetal Neonatal Med. 2019 Feb;32(3):377-383
pubmed: 28889777
Ultrasound Obstet Gynecol. 2012 Dec;40(6):659-64
pubmed: 22581671
Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31
pubmed: 21472815
Natl Vital Stat Rep. 2016 Jun;65(3):1-15
pubmed: 27309256
J Matern Fetal Neonatal Med. 2019 May;32(9):1485-1491
pubmed: 29251009
Taiwan J Obstet Gynecol. 2015 Oct;54(5):580-2
pubmed: 26522114
J Obstet Gynaecol. 2018 Nov;38(8):1054-1059
pubmed: 29566566
J Ultrasound Med. 2017 May;36(5):999-1007
pubmed: 28150324
Am J Obstet Gynecol. 1985 Feb 1;151(3):333-7
pubmed: 3881966
Obstet Gynecol. 2016 Apr;127(4):726-34
pubmed: 26959201
Contemp Clin Trials. 2011 Sep;32(5):731-40
pubmed: 21616172
Paediatr Perinat Epidemiol. 2001 Jul;15 Suppl 2:78-89
pubmed: 11520402
Ultrasound. 2018 Feb;26(1):54-62
pubmed: 29456583
J Perinat Med. 2018 Oct 25;46(8):900-904
pubmed: 29543592

Auteurs

Janina Goletzke (J)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Mirja Pagenkemper (M)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Christian Wiessner (C)

Institute of Medical Biometry and Epidemiology, University Medical-Centre Hamburg Eppendorf, Hamburg, Germany.

Franziska Rüber (F)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Petra Arck (P)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Kurt Hecher (K)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Anke Diemert (A)

Department of Obstetrics and Fetal Medicine, University Medical-Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. a.diemert@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH